Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|October 1, 1982
A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT)Y C Chang, G Falkson, D C Tormey, et al.
American Journal of Hematology|May 1, 1990
"Idiopathic thrombocytopenic purpura-like syndrome" treated with interferon in a patient with lung cancerB L Rapoport, G Falkson, A S Alberts, et al.
American Journal of Clinical Oncology|August 1, 1995
Hepatocellular carcinoma. An ECOG randomized phase II study of beta-interferon and menogarilG Falkson, S Lipsitz, E Borden, et al.
Cancer Treatment Reports|February 1, 1979
Acute leukemia as a complication of long-term treatment of advanced breast cancerM A Portugal, H C Falkson, K Stevens, et al.
Cancer|February 15, 1986
Hepatitis-B as a prognostic discriminant in patients with primary liver cancerG Falkson, R H Böhmer, M Adam, et al.
Tumori|October 31, 1990
A phase II study of idarubicin and prednisone in multiple myelomaA S Alberts, G Falkson, B L Rapoport, et al.
Cancer Clinical Trials|January 1, 1981
Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancerY C Chang, G Falkson, D C Tormey, et al.
Cancer Treatment Reports|August 1, 1982
Combined doxorubicin and radiation therapy in malignant pleural mesotheliomaC Sinoff, G Falkson, A G Sandison, et al.
American Journal of Clinical Oncology|February 1, 1992
A phase II study of 5-fluorouracil and leucovorin in advanced carcinoma of the esophagusA S Alberts, L Schoeman, W Burger, et al.
British Journal of Cancer|May 1, 1976
Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancerG M Macnab, J M Urbanowicz, E W Geddes, et al.
Pageof 20